Skip to main content

Table 2 Baseline characteristics of study infants at delivery (%)

From: Artemisinin-based combination therapy during pregnancy: outcome of pregnancy and infant mortality: a cohort study

  AL ASAQ MQAS DHAPQ p-valuea
N Value N Value N Value N Value
Live births by country 0.85
 Burkina Faso 280 278 (99.3) 279 278 (99.6) 275 268 (97.5)    
 Ghana    245 235 (95.9) 241 229 (95.0) 252 243 (96.4)  
 Malawi 276 269 (97.5) 269 262 (97.4)    270 268 (99.3)  
 Zambia 282 275 (97.5)    273 268 (98.2) 264 254 (96.2)  
 Birth asphyxia 706 19 (2.7) 635 42 (6.6) 658 44 (6.7) 648 39 (6.0) 0.91
 Congenital abnormalityb 815 17 (2.1) 757 12 (1.6) 751 12 (1.6) 742 6 (0.8) 0.35
 Prematurityc 838 78 (9.3) 793 25 (3.2) 789 57 (7.2) 786 70 (8.9) 0.65
 Congenital malariad 808 7 (0.9) 727 2 (0.3) 719 1 (0.1) 711 1 (0.1) 0.15
 Anaemia at birthd 793 12 (1.5) 720 7 (1.0) 713 10 (1.4) 696 10 (1.4) 0.36
 Birth weight mean (SD) 804 2856 (452) 742 2873 (463) 733 2860 (460) 720 2889 (463) 0.56
 LBW < 2500 g 804 138 (17.2) 742 118 (15.9) 733 119 (16.2) 720 105 (14.6) 0.54
  1. aAdjusted by country
  2. bReported as SAE at delivery
  3. cCalculated by Ballard score
  4. dCord blood at 14 g/dL cut off for congenital anaemia and cord blood for malaria